GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation

GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) represent a cornerstone in the treatment of diabetes and obesity and have emerged as a promising option for other metabolic disorders, including hepatic steatosis. Recent evidence highlights the direct and indirect anti-inflammatory properties of...

Full description

Saved in:
Bibliographic Details
Main Authors: Giulia Migliorisi, Roberto Gabbiadini, Arianna Dal Buono, Matteo Ferraris, Giuseppe Privitera, Lorenzo Petronio, Peter Bertoli, Cristina Bezzio, Alessandro Armuzzi
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Immunology
Subjects:
IBD
GLP-1
GLP-1 receptor agonists
diabetes
obesity
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1610368/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2025.1610368/full

Similar Items